Alaunos Therapeutics (NASDAQ: TCRT) has filed an amended annual report (10-K/A) to provide detailed information on its board structure, executive and ...
Bearish
Alaunos Therapeutics (NASDAQ:TCRT) has received a notice from Nasdaq for non-compliance with its listing rule requiring a minimum of $2.5 million in s...
Bearish
Alaunos Therapeutics faces potential delisting from Nasdaq after failing to meet the minimum stockholders' equity requirement, reporting $2.153 millio...